ODI Pharma AB (publ) (FRA:6OD)
0.3260
-0.0080 (-2.40%)
Last updated: Jan 28, 2026, 8:15 AM CET
ODI Pharma AB Market Cap
ODI Pharma AB has a market cap or net worth of €6.75 million as of January 30, 2026. Its market cap has increased by 59.61% in one year.
Market Cap
6.75M
Enterprise Value
6.48M
Revenue
810.28K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.33
Market Cap Chart
Since January 27, 2020, ODI Pharma AB's market cap has decreased from 12.26M to 6.75M, a decrease of -44.93%. That is a compound annual growth rate of -9.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 6.75M | -7.83% |
| Dec 30, 2025 | 7.32M | 137.56% |
| Dec 30, 2024 | 3.08M | -54.84% |
| Dec 29, 2023 | 6.83M | 27.79% |
| Dec 30, 2022 | 5.34M | -26.94% |
| Dec 30, 2021 | 7.31M | -0.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Turbon AG | 8.94M |
| AHT Syngas Technology | 8.85M |
| MedNation AG | 8.65M |
| Altech Advanced Materials AG | 7.61M |
| Bio-Gate AG | 7.54M |
| BHB Brauholding Bayern-Mitte AG | 6.63M |
| BigRep SE | 5.97M |
| H2 Core AG | 5.32M |